We are live on
!
Find out more
HCM
Highline Capital Management Portfolio holdings
AUM
$53.5M
1-Year Est. Return
21.72%
This Fund
S&P 500
This Quarter
Est. Return
-5.65%
1 Year Est. Return
-21.72%
3 Year Est. Return
+197.64%
5 Year Est. Return
+251.63%
10 Year Est. Return
–
AUM
$411M
AUM Growth
-$221M
(-35%)
Cap. Flow
-$182M
Cap. Flow
% of AUM
-44.35%
Top 10 Holdings %
Top 10 Hldgs %
66.85%
Holding
38
New
16
Increased
3
Reduced
6
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$37.2M |
| 2 |
VeriSign
VRSN
|
+$34.1M |
| 3 |
Charter Communications
CHTR
|
+$32.6M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$25.8M |
| 5 |
Avantor
AVTR
|
+$25.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tyson Foods
TSN
|
+$47.6M |
| 2 |
LPL Financial
LPLA
|
+$47.6M |
| 3 |
Boston Scientific
BSX
|
+$46.7M |
| 4 |
Meta Platforms (Facebook)
META
|
+$44.3M |
| 5 |
GRA
W.R. Grace & Co.
GRA
|
+$41.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.04% |
| 2 | Consumer Discretionary | 24.45% |
| 3 | Healthcare | 21.03% |
| 4 | Consumer Staples | 10.18% |
| 5 | Communication Services | 7.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Amazon
AMZN
$2.5T
| $37.5M | 9.12% |
+384,200
| New | +$37.2M |
|
|
2
VeriSign
VRSN
$25.3B
| $31.3M | 7.62% |
+173,680
| New | +$34.1M |
|
|
CTLT
3
DELISTED
CATALENT, INC.
CTLT
| $31.1M | 7.58% |
599,440
+8,100
| +1% | +$442K |
|
4
Alibaba
BABA
$269B
| $30.1M | 7.33% |
154,857
-46,600
| -23% | -$9.73M |
|
|
5
Charter Communications
CHTR
$14.7B
| $29.1M | 7.08% |
+66,650
| New | +$32.6M |
|
6
Salesforce
CRM
$134B
| $26.4M | 6.42% |
183,235
-59,600
| -25% | -$10.2M |
|
|
ATVI
7
DELISTED
Activision Blizzard
ATVI
| $25.8M | 6.29% |
+434,050
| New | +$25.8M |
|
8
Dollar General
DG
$25.9B
| $21.9M | 5.33% |
+145,000
| New | +$22.4M |
|
9
JD.com
JD
$40.8B
| $21.2M | 5.15% |
+522,400
| New | +$20.9M |
|
10
Commercial Metals
CMC
$7.63B
| $20.2M | 4.93% |
1,281,542
-266,457
| -17% | -$5.07M |
|
11
Cal-Maine
CALM
$4.28B
| $19.9M | 4.85% |
+452,900
| New | +$17.1M |
|
|
12
Avantor
AVTR
$7.81B
| $19.9M | 4.84% |
+1,591,000
| New | +$25.5M |
|
13
RingCentral
RNG
$4.05B
| $16.5M | 4.02% |
+78,000
| New | +$16.1M |
|
14
Humana
HUM
$46.7B
| $15.5M | 3.77% |
49,300
-22,700
| -32% | -$7.66M |
|
15
DHT Holdings
DHT
$2.97B
| $12.5M | 3.04% |
+1,625,383
| New | +$10.3M |
|
16
TJX Companies
TJX
$170B
| $11.7M | 2.85% |
+244,500
| New | +$14.1M |
|
17
CrowdStrike
CRWD
$187B
| $11M | 2.69% |
+793,600
| New | +$11.2M |
|
18
Moderna
MRNA
$21.5B
| $7.49M | 1.82% |
250,000
+100,000
| +67% | +$2.3M |
|
19
Valero Energy
VLO
$89.8B
| $7.21M | 1.75% |
+158,900
| New | +$11.5M |
|
20
Passage Bio
PASG
$15.9M
| $5.82M | 1.42% |
+18,467
| New | +$5.78M |
|
21
UroGen Pharma
URGN
$2B
| $3.97M | 0.97% |
222,776
-626,702
| -74% | -$16.9M |
|
22
Upwork
UPWK
$1.09B
| $1.92M | 0.47% |
+296,900
| New | +$2.55M |
|
23
Alector
ALEC
$164M
| $1.83M | 0.45% |
75,814
-138,700
| -65% | -$3.54M |
|
24
Arcturus Therapeutics
ARCT
$157M
| $765K | 0.19% |
56,304
+24,900
| +79% | +$319K |
|
|
FPAC.WS
25
DELISTED
Far Point Acquisition Corporation Warrants, exercisable for one share of Class A Common Stock for $1
FPAC.WS
| $168K | 0.04% |
+310,802
| New | +$461K |
|
Similar funds
NHSP
DTIM
BI
MCAI
PCM
FC
AEPIP
SAM
Highline Capital Management's Q1 2020 Portfolio in Review
As of Q1 2020, Highline Capital Management held 38 positions worth $411M, down 35% from $631M the previous quarter. Its ten largest holdings account for 67% of the portfolio.
Highline Capital Management withdrew a net $182M in Q1 2020, closing 13 positions and reducing 6 holdings. Its most notable exit was Tyson Foods, an estimated $47.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Highline Capital Management opened a new position in Amazon worth $37.5M.
- Highline Capital Management's largest Q1 2020 buy was Amazon: 384,200 shares worth $37.5M.
- Highline Capital Management added most to Moderna in Q1 2020, an estimated $2.3M increase.
- Highline Capital Management's biggest Q1 2020 reduction was UroGen Pharma, cutting an estimated $16.9M.
- Highline Capital Management fully exited Tyson Foods in Q1 2020, selling an estimated $47.6M.
- Highline Capital Management's ten largest holdings make up 67% of its $411M portfolio in Q1 2020.
- Highline Capital Management opened 16 new positions and closed 13 in Q1 2020.
- Highline Capital Management's portfolio value fell 35% quarter-over-quarter to $411M.
Based on Highline Capital Management's 13F filing for Q1 2020, filed 15 May 2020.